FXN and Friedreich ataxia: Our study aimed to investigate which drug and/or which combination of drugs will demonstrate to be most efficacious to increase the expression level of FXN mRNA, consequently improving mitochondrial health in patients’ cells and FA models’ neurons and cardiomyocytes in vitro and proving to ameliorate the motor skills in vivo in FA mouse models.